DTPA與peptide,蛋白質或其他可追尋目標之化合物結合(conjugation)後,再與放射性同位素離子螯合之產物在核子醫學上有許多應用。目前用來與peptide 或蛋白質結合之DTPA衍生物有一些缺點.有人為改進此接合步驟,而開發單活性配位基DTPA衍生物,但需要六個反應步驟才能完成。本文製備一全酯化之DTPA,然後再進行選擇性水解去掉一個酯基,只要兩個反應步驟就可得單活性配位基DTPA衍生物,產率必然比文獻方法高。通常純度也會較好。 在這過程中,如R基為乙基,則總產率為55.5%;如為第三丁基,則總產率為32.9﹪。
DTPA (diethylenetriamine pentaacetic acid) is a useful bifunctional chelator which can be conjugated to a peptide, a protein or other target-seeking compounds and, in the mean time, chelated to a radioisotope. The resulting compounds can be used as radiopharmaceuticals. In the conjugation of DTPA to target-seeking compounds, for the purpose of avoiding the occurrence of bis-conjugated by-products which require tedious separation, mono-active DTPA has been developed. However, the current synthesis of mono-active DTPA takes six steps, which is lengthy and high cost. In this thesis, a two steps process to accomplish this synthesis was reported. Therein, a penta-ester of DTPA is prepared followed by a selective hydrolysis to obtain mono-active DTPA. The total yields are 55.5% and 32.9% for R = ethyl and t-butyl, respectively.